glp-1 stomach paralysis legal team in west virginia medications like Ozempic, Wegovy, and Mounjaro have been linked to blindness and vision loss. If you experienced vision problems after taking a GLP-1 drug, you may have options. Contact us Thousands of patients are suing

J Clin Endocrinol Metab 2007;92:491-6.ArticlePubMed 43

These insights are based on Ro's GLP-1 Insurance Coverage Checker user data between August 13, 2024 - April 17, 2025

Weight creeps up despite genuine effort

Abstract Glucagon-like peptide-1 medicines are being prescribed to growing numbers of patients worldwide, for type 2 diabetes, obesity and associated comorbidities, including cardiovascular disease, peripheral artery disease and obstructive sleep apnea, and are revolutionizing public health strategies for these conditions

Around three and a half years ago, my then internet friend (and now my cofounder at my virtual clinic, Vineyard), Spencer Nadolsky, DO, tweeted something that hit me hard

With the potential to not only support weight loss but also improve long-term metabolic health, GLP-1s offer powerful tools for those struggling with obesity, type 2 diabetes, and other metabolic conditions